|
1
|
Miller RD: Miller's anesthesia. Eighth.
Philadelphia: Elsevier Saunders; pp. 822–831. 2015
|
|
2
|
Vanhorebeek I, Gunst J and Van den Berghe
G: Critical care management of stress-induced hyperglycemia. Curr
Diab Rep. 18:172018. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Van den Berghe G, Wilmer A, Hermans G,
Meersseman W, Wouters PJ, Milants I, Van Wijngaerden E, Bobbaers H
and Bouillon R: Intensive insulin therapy in the medical ICU. N
Engl J Med. 354:449–461. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Yasuda Y, Fukushima Y, Kaneki M and Martyn
JA: Anesthesia with propofol induces insulin resistance
systemically in skeletal and cardiac muscles and liver of rats.
Biochem Biophys Res Commun. 431:81–85. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Zhou L, Wang L, Yang B, Zeng J, Zhang Q,
Lei H and Xu S: Protective effect of pretreatment with propofol
against tumor necrosis factor-α-induced hepatic insulin resistance.
Exp Ther Med. 10:289–294. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Milne SE, Troy A, Irwin MG and Kenny GN:
Relationship between bispectral index, auditory evoked potential
index and effect-site EC50 for propofol at two clinical end-points.
Br J Anaesth. 90:127–131. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Smith C, McEwan AI, Jhaveri R, Wilkinson
M, Goodman D, Smith LR, Canada AT and Glass PS: The interaction of
fentanyl on the Cp50 of propofol for loss of consciousness and skin
incision. Anesthesiology. 81:820–828, Discussion 26A. 1994.
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Hsing CH, Chen YH, Chen CL, Huang WC, Lin
MC, Tseng PC, Wang CY, Tsai CC, Choi PC and Lin CF: Anesthetic
propofol causes glycogen synthase kinase-3β-regulated
lysosomal/mitochondrial apoptosis in macrophages. Anesthesiology.
116:868–881. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Driessen GJ, IJspeert H, Wentink M, Yntema
HG, van Hagen PM, van Strien A, Bucciol G, Cogulu O, Trip M,
Nillesen W, et al: Increased PI3K/Akt activity and deregulated
humoral immune response in human PTEN deficiency. J Allergy Clin
Immunol. 138:1744–1747.e5. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Yue S, Li J, Lee SY, Lee HJ, Shao T, Song
B, Cheng L, Masterson TA, Liu X, Ratliff TL and Cheng JX:
Cholesteryl ester accumulation induced by PTEN loss and PI3K/AKT
activation underlies human prostate cancer aggressiveness. Cell
Metab. 19:393–406. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Bleau AM, Hambardzumyan D, Ozawa T,
Fomchenko EI, Huse JT, Brennan CW and Holland EC: PTEN/PI3K/Akt
pathway regulates the side population phenotype and ABCG2 activity
in glioma tumor stem-like cells. Cell Stem Cell. 4:226–235. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Wishart MJ and Dixon JE: PTEN and
myotubularin phosphatases: From 3-phosphoinositide
dephosphorylation to disease. Trends Cell Biol. 12:579–585. 2002.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Elbashir SM, Harborth J, Lendeckel W,
Yalcin A, Weber K and Tuschl T: Duplexes of 21-nucleotide RNAs
mediate RNA interference in cultured mammalian cells. Nature.
411:494–498. 2001. View
Article : Google Scholar : PubMed/NCBI
|
|
14
|
Shi XP, Zong AN, Tao J and Wang LZ: Study
of instructive notions with respect to caring for laboratory
animals. J China Med Univ. 36:4932007.
|
|
15
|
Seglen PO: Preparation of isolated rat
liver cells. Methods Cell Biol. 13:29–83. 1976. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Casciano DA: Development and utilization
of primary hepatocyte culture systems to evaluate metabolism, DNA
binding, and DNA repair of xenobiotics. Drug Metab Rev. 32:1–13.
2000. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Lebovitz HE: Insulin resistance:
Definition and consequences. Exp Clin Endocrinol Diabetes. 109
Suppl 2:S135–S148. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Reaven GM: Banting lecture 1988. Role of
insulin resistance in human disease. Diabetes. 37:1595–1607. 1988.
View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Fahy BG, Sheehy AM and Coursin DB: Glucose
control in the intensive care unit. Crit Care Med. 37:1769–1776.
2009. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
van den Berghe G, Wouters P, Weekers F,
Verwaest C, Bruyninckx F, Schetz M, Vlasselaers D, Ferdinande P,
Lauwers P and Bouillon R: Intensive insulin therapy in critically
ill patients. N Engl J Med. 345:1359–1367. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Li J, Yen C, Liaw D, Podsypanina K, Bose
S, Wang SI, Puc J, Miliaresis C, Rodgers L, McCombie R, et al:
PTEN, a putative protein tyrosine phosphatase gene mutated in human
brain, breast, and prostate cancer. Science. 275:1943–1947. 1997.
View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Steck PA, Pershouse MA, Jasser SA, Yung
WK, Lin H, Ligon AH, Langford LA, Baumgard ML, Hattier T, Davis T,
et al: Identification of a candidate tumour suppressor gene, MMAC1,
at chromosome 10q23.3 that is mutated in multiple advanced cancers.
Nat Genet. 15:356–362. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Li DM and Sun H: TEP1, encoded by a
candidate tumor suppressor locus, is a novel protein tyrosine
phosphatase regulated by transforming growth factor beta. Cancer
Res. 57:2124–2129. 1997.PubMed/NCBI
|
|
25
|
Chu EC and Tarnawski AS: PTEN regulatory
functions in tumor suppression and cell biology. Med Sci Monit.
10:RA235–RA241. 2004.PubMed/NCBI
|
|
26
|
Sha SH, Chen FQ and Schacht J: PTEN
attenuates PIP3/Akt signaling in the cochlea of the aging CBA/J
mouse. Hear Res. 264:86–92. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Leslie NR, Bennett D, Lindsay YE, Stewart
H, Gray A and Downes CP: Redox regulation of PI 3-kinase signalling
via inactivation of PTEN. EMBO J. 22:5501–5510. 2003. View Article : Google Scholar : PubMed/NCBI
|
